Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Isotechnika Pharma Inc IPHAF

GREY:IPHAF - Post Discussion

Isotechnika Pharma Inc > No Comments from/about the Special Meeting!
View:
Post by ISAloser247 on Dec 16, 2010 9:56am

No Comments from/about the Special Meeting!


...the cocky and the arrogant,  are left to whimper and sleaze away! 


Comment by antoninus on Dec 16, 2010 11:38am
isaloser - how much stock you own? and IF you do own shares, what price do you own them at? your posts are frankly useless...you seem to like talking to yourself. You also seem to have a strong hate on for this company. I dont get it....yes, they have made mistakes and yes, we should trade higher than where we are. BUT, dont you want this drug to make it to market if it helps people with ...more  
Comment by wuker on Dec 16, 2010 5:13pm
Comment by wuker on Dec 16, 2010 8:54pm
Don't know what happened with my last post. At the meeting yesterday we had a presentation updating the plans for the future. I'm going a bit from memory so do your own dd. Companies focus will be on TX. We need 2 phase 3 trials. First one will cost approx 27.4 million which the company feels they are able to do after the Iljen deal. Company still retains the EU rights which they are ...more  
Comment by pirate4 on Dec 16, 2010 10:57pm
Biotech may be ready to pop. Take a good hard look at BLU
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities